Related posts:

1. DBV Technologies Receives IND Clearance From FDA To Begin Clinical Trial In Peanut Allergy DBV Technologies (DBV), a biotech company specializing in food allergy with innovative products for diagnosis and treatment, announced the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application....
2. Share of Cost, Release Of Official Food Allergy Treatment Guidelines – Protocol Also Designed To Aid Physicians In Diagnosis Share of Cost, Release Of Official Food Allergy Treatment Guidelines - Protocol Also Designed To Aid Physicians In Diagnosis...
3. Share of Cost, Medi-Cal, NICE Consults On Draft Guideline On Food Allergies In Children NICE has opened the consultation on its draft clinical guideline on the diagnosis and assessment of food allergies in children and young people. Its aim is to support GPs and other health professionals in primary care and community settings in recognising the signs and symptoms of food allergy, by giving clear recommendations on taking allergy-focussed […]...
4. Share of Cost, Allergy Shots Are Helpful For Some Asthmatics, Risky For Others Allergy shots can reduce symptoms of asthma, use of inhaled medications and allergy-related asthma attacks, confirms an updated review of studies. Yet, the treatment can also cause systemic side effects that range from a stuffy nose to fatal anaphylactic shock....
5. Share of Cost, Fresh Funding Gives Hope To A New Generation Of Asthma And Allergy Treatment Share of Cost, Fresh Funding Gives Hope To A New Generation Of Asthma And Allergy Treatment...
6. Comprehensive US Food Allergy Guidelines Issued By NIH-Sponsored Panel An expert panel sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has issued comprehensive U.S. guidelines to assist health care professionals in diagnosing food allergy and managing the care of people with the disease....
7. Consortium Of Food Allergy Research Led By Mount Sinai Benefits From $29.9 Million Grant Mount Sinai School of Medicine has announced that the National Institutes of Health (NIH) has renewed its funding of the Consortium of Food Allergy Research (CoFAR), providing an additional $29.9 million toward genetic research and the prevention and treatment of food allergy. Mount Sinai is the primary research site for CoFAR, leading seven other institutions […]...
8. European Survey Show Significant Impact Of ADHD At School And Home, Yet Parents Wait Over Two Years For An ADHD Diagnosis Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced the results of a new European survey that found children with ADHD have statistically significant impairments in all aspects of life investigated vs. children without ADHD. Yet, parents take an average of 26.8 months to achieve a diagnosis for their child....
9. Share of Cost, Einstein Receives $4 Million To Test HPV Microbicide Share of Cost, Einstein Receives $4 Million To Test HPV Microbicide — The National Cancer Institute has awarded Albert Einstein College of Medicine of Yeshiva University $4.1 million to test the microbicide Carraguard® against the human papillomavirus (HPV), which causes cervical cancer. The research will evaluate the efficacy of Carraguard®, a clear gel made from […]...
10. Blue Shield Of California Dental Plan Highlights Blue Shield Of California Dental Plan Higlights...
11. 5.9 Million US Kids Have Food Allergies Approximately 8% of US children have some kind of food allergy, researchers from Northwestern University Feinberg School of Medicine reported in the journal Pediatrics. 38.7% of those with a food allergy have a history of severe reactions, while 30.4% are allergic to several foods, the authors added....
12. Olmstead – Community Integration for Everyone Information about the Supreme Court’s decision in Olmstead v. L.C., a ruling that requires states to eliminate unnecessary segregation of persons with disabilities and make sure that they receive services in the most integrated setting possible. Includes information about the “Year of Community Living” and enforcement of title II of the Americans with Disabilities Act. […]...
13. Patients Living With Gerd Now Have A New Treatment Option For Improved And Sustained Symptom Relief Takeda is pleased to announce that DEXILANT™ (dexlansoprazole) is now available in Canada. DEXILANT is the first and only proton pump inhibitor (PPI) with a novel DUAL DELAYED RELEASE technology, which delivers two separate doses of medication at different times providing improved and sustained symptom relief throughout the day and night....
14. DOJ to Intervene in Texas Case to Enforce Supreme Court’s Olmstead Decision On the 13th Anniversary of the Olmstead Decision, the U.S. Department of Justice (DOJ) is seeking to intervene in Steward, et al. v. Perry, et al., a case filed on behalf of thousands of Texans with developmental disabilities, to enforce their right under the Americans with Disabilities Act (ADA) to receive services provided by the state in […]...
15. New York Share of Cost, Zegerid OTC Provides Greater And Faster Acid Control Than Prevacid 24HR According To Head-To-Head Clinical Study New York Share of Cost, Zegerid OTC Provides Greater And Faster Acid Control Than Prevacid 24HR According To Head-To-Head Clinical Study: Merck Consumer Care has announced results of a head-to-head clinical study showing that ZEGERID OTC™ offers greater and faster acid control than Prevacid® 24HR. While acid control is an industry standard measure for acid-reducing […]...